Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Operating-Expenses" stands at 215.70 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2024.
Shionogi & Co. Ltd.'s second quarter result of 55.11 Billion JPY for the item "Operating Expenses" represents an increase of 5.23 percent compared to it's first quarter result.
Also, Shionogi & Co. Ltd.'s second quarter result of 55.11 Billion JPY for the item "Operating Expenses" represents an increase of 7.87 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s second quarter result of 215.70 Billion JPY for the item "Operating Expenses" represents an increase of 1.90 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.5238 percent compared to the value the year prior.
The 1 year change in percent is 0.5238.
The 3 year change in percent is 14.03.
The 5 year change in percent is 56.77.
The 10 year change in percent is 53.68.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Expenses | 905,699,262,464.00 |
![]() | Johnson & Johnson - Operating Expenses | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Expenses | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Expenses | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Expenses | 280,205,508,085.11 |